SYDNEY (Reuters) – Australia on Monday approved the Pfizer-BioNotech COVID-19 vaccine for use, but warned of AstraZeneca’s international production problems, which means the country has a planned local built The shot will …
Read More »
Zuzana Szymanska, by Stefan Nitschke 21 January (Reuters) – German researchers have paralyzed mice to regrow after spinal cord injuries, reestablishing neural links considered irreparable in mammals using a designer protein injected …
Read More »
NEW YORK, Jan 14 (Reuters) – General Electric Co accused Siemens Energy AG of using stolen trade secrets for rigged bids for lucrative contracts supplying gas turbines to public utilities, and improper …
Read More »
LONDON (Reuters) – Investors closed the second impeachment of US President Donald Trump’s record and focused instead on reports on Thursday that his replacement, Joe Biden, would later host a new US …
Read More »
LONDON (Reuters) – European stocks rose and the dollar rose after a volatile start on Wednesday, while 10-year US Treasury yields fell from 10-month highs, against talk of Fed support by policymakers …
Read More »
LONDON (Reuters) – European stocks rose and the dollar rose after a volatile start on Wednesday, while 10-year US Treasury yields fell from 10-month highs, against talk of Fed support by policymakers …
Read More »
* Graphic: 2020 asset performance tmsnrt.rs/2yaDPgn * Graphic: World FX rates in 2020 tmsnrt.rs/2egbfVh LONDON, Jan 11 (Reuters) – World stocks slipped from record highs on Monday as cautiousness in rising coronovirus …
Read More »
Johannesburg, 5 January (Reuters) – A type of coronovirus first discovered in South Africa is unlikely to completely rule out the immunological effects of vaccines, a researcher studying it told Reuters. British …
Read More »
Johannesburg, 5 January (Reuters) – A type of coronovirus first discovered in South Africa is unlikely to completely rule out the immunological effects of vaccines, a researcher studying it told Reuters. British …
Read More »
Johannesburg, 5 January (Reuters) – A type of coronovirus first discovered in South Africa is unlikely to completely rule out the immunological effects of vaccines, a researcher studying it told Reuters. British …
Read More »